These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 36564435)
1. Haploinsufficiency of Shank3 increases the orientation selectivity of V1 neurons. Ortiz-Cruz CA; Marquez EJ; Linares-García CI; Perera-Murcia GR; Ramiro-Cortés Y Sci Rep; 2022 Dec; 12(1):22230. PubMed ID: 36564435 [TBL] [Abstract][Full Text] [Related]
2. Shank3 deletion in PV neurons is associated with abnormal behaviors and neuronal functions that are rescued by increasing GABAergic signaling. Pagano J; Landi S; Stefanoni A; Nardi G; Albanesi M; Bauer HF; Pracucci E; Schön M; Ratto GM; Boeckers TM; Sala C; Verpelli C Mol Autism; 2023 Aug; 14(1):28. PubMed ID: 37528484 [TBL] [Abstract][Full Text] [Related]
4. A 29 Mainland Chinese cohort of patients with Phelan-McDermid syndrome: genotype-phenotype correlations and the role of SHANK3 haploinsufficiency in the important phenotypes. Xu N; Lv H; Yang T; Du X; Sun Y; Xiao B; Fan Y; Luo X; Zhan Y; Wang L; Li F; Yu Y Orphanet J Rare Dis; 2020 Nov; 15(1):335. PubMed ID: 33256793 [TBL] [Abstract][Full Text] [Related]
5. Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons. Yi F; Danko T; Botelho SC; Patzke C; Pak C; Wernig M; Südhof TC Science; 2016 May; 352(6286):aaf2669. PubMed ID: 26966193 [TBL] [Abstract][Full Text] [Related]
6. Early Restoration of Jaramillo TC; Xuan Z; Reimers JM; Escamilla CO; Liu S; Powell CM eNeuro; 2020; 7(3):. PubMed ID: 32327468 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice. Vicidomini C; Ponzoni L; Lim D; Schmeisser MJ; Reim D; Morello N; Orellana D; Tozzi A; Durante V; Scalmani P; Mantegazza M; Genazzani AA; Giustetto M; Sala M; Calabresi P; Boeckers TM; Sala C; Verpelli C Mol Psychiatry; 2017 May; 22(5):689-702. PubMed ID: 27021819 [TBL] [Abstract][Full Text] [Related]
8. Developmental social communication deficits in the Shank3 rat model of phelan-mcdermid syndrome and autism spectrum disorder. Berg EL; Copping NA; Rivera JK; Pride MC; Careaga M; Bauman MD; Berman RF; Lein PJ; Harony-Nicolas H; Buxbaum JD; Ellegood J; Lerch JP; Wöhr M; Silverman JL Autism Res; 2018 Apr; 11(4):587-601. PubMed ID: 29377611 [TBL] [Abstract][Full Text] [Related]
9. Neural Stem Cells from Shank3-ko Mouse Model Autism Spectrum Disorders. Grasselli C; Carbone A; Panelli P; Giambra V; Bossi M; Mazzoccoli G; De Filippis L Mol Neurobiol; 2020 Mar; 57(3):1502-1515. PubMed ID: 31773410 [TBL] [Abstract][Full Text] [Related]
10. Increased rates of cerebral protein synthesis in Shank3 knockout mice: Implications for a link between synaptic protein deficit and dysregulated protein synthesis in autism spectrum disorder/intellectual disability. Torossian A; Saré RM; Loutaev I; Smith CB Neurobiol Dis; 2021 Jan; 148():105213. PubMed ID: 33276083 [TBL] [Abstract][Full Text] [Related]
11. An IGFBP2-derived peptide promotes neuroplasticity and rescues deficits in a mouse model of Phelan-McDermid syndrome. Burgdorf JS; Yoon S; Dos Santos M; Lammert CR; Moskal JR; Penzes P Mol Psychiatry; 2023 Mar; 28(3):1101-1111. PubMed ID: 36481930 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of two Shank3 and the Cacna1c mouse models of autism spectrum disorder. Kabitzke PA; Brunner D; He D; Fazio PA; Cox K; Sutphen J; Thiede L; Sabath E; Hanania T; Alexandrov V; Rasmusson R; Spooren W; Ghosh A; Feliciano P; Biemans B; Benedetti M; Clayton AL Genes Brain Behav; 2018 Jan; 17(1):4-22. PubMed ID: 28753255 [TBL] [Abstract][Full Text] [Related]
13. The Role of Thioredoxin System in Shank3 Mouse Model of Autism. Bazbaz W; Kartawy M; Hamoudi W; Ojha SK; Khaliulin I; Amal H J Mol Neurosci; 2024 Sep; 74(4):90. PubMed ID: 39347996 [TBL] [Abstract][Full Text] [Related]
14. A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype-phenotype correlation and identification of an atypical case. Samogy-Costa CI; Varella-Branco E; Monfardini F; Ferraz H; Fock RA; Barbosa RHA; Pessoa ALS; Perez ABA; Lourenço N; Vibranovski M; Krepischi A; Rosenberg C; Passos-Bueno MR J Neurodev Disord; 2019 Jul; 11(1):13. PubMed ID: 31319798 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of Trpv4 rescues circuit and social deficits unmasked by acute inflammatory response in a Shank3 mouse model of Autism. Tzanoulinou S; Musardo S; Contestabile A; Bariselli S; Casarotto G; Magrinelli E; Jiang YH; Jabaudon D; Bellone C Mol Psychiatry; 2022 Apr; 27(4):2080-2094. PubMed ID: 35022531 [TBL] [Abstract][Full Text] [Related]
16. Shank3 mutation in a mouse model of autism leads to changes in the S-nitroso-proteome and affects key proteins involved in vesicle release and synaptic function. Amal H; Barak B; Bhat V; Gong G; Joughin BA; Wang X; Wishnok JS; Feng G; Tannenbaum SR Mol Psychiatry; 2020 Aug; 25(8):1835-1848. PubMed ID: 29988084 [TBL] [Abstract][Full Text] [Related]
17. Early life sleep disruption potentiates lasting sex-specific changes in behavior in genetically vulnerable Shank3 heterozygous autism model mice. Lord JS; Gay SM; Harper KM; Nikolova VD; Smith KM; Moy SS; Diering GH Mol Autism; 2022 Aug; 13(1):35. PubMed ID: 36038911 [TBL] [Abstract][Full Text] [Related]
18. Disrupted extracellular matrix and cell cycle genes in autism-associated Shank3 deficiency are targeted by lithium. Ioannidis V; Pandey R; Bauer HF; Schön M; Bockmann J; Boeckers TM; Lutz AK Mol Psychiatry; 2024 Mar; 29(3):704-717. PubMed ID: 38123724 [TBL] [Abstract][Full Text] [Related]